NIH-funded research Fellowship grant

How stress responses in lung cancer affect immune checkpoint regulation

Official title: Immune Checkpoint Regulation by the Integrated Stress Response Pathway in Lung Ca

Funded at Ut Southwestern Medical Center · NIH-11052554 · Data updated 2026-11-12

This study is looking at how lung cancer cells handle stress and how that helps them hide from the immune system, with the goal of finding better ways to improve treatments for lung cancer patients.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startApril 1, 2023
Project endMarch 31, 2026
Funding year2025
Award (this year)$80,224
NIH project number5F32CA274982-03
Project IDNIH-11052554 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with non-small cell lung cancer (NSCLC) who may be receiving or considering PD-1/PD-L1 targeted therapies.

Less likely to help

Patients with other types of cancer or those who are not eligible for PD-1/PD-L1 therapies may not benefit from this research.

What this research studies

This research investigates how lung cancer cells respond to stress and how this affects their ability to evade the immune system. It focuses on the role of the integrated stress response (ISR) in regulating immune checkpoint proteins like PD-L1, which can suppress the body's anti-tumor immune response. By understanding these mechanisms, the research aims to identify new strategies to enhance the effectiveness of existing cancer therapies, particularly those targeting the PD-1/PD-L1 pathway. Patients may benefit from insights that could lead to improved treatment options for lung cancer.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for lung cancer by overcoming resistance to current therapies.

How similar studies have gone: Previous research has shown promising results in targeting the PD-1/PD-L1 pathway, but the specific role of the ISR in this context is still being explored.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Thomas-Jardin, Shayna — Ut Southwestern Medical Center
  • Study coordinator: Thomas-Jardin, Shayna

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.